Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Solid Tumor, Adult × Catalytic Domain × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Solid Tumor, Adult 1

Interventions

pembrolizumab 3 toripalimab 1 spartalizumab 1 sotorasib 1 pazopanib 1 palbociclib 1 abemaciclib 1 Trastuzumab 1 Therapeutics 1 Jupiter 1 Interleukin-2 1 Immune Checkpoint Inhibitors 1 Fulvestrant 1 EBI-005 1 Cetuximab 1 Catalytic Domain 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06056323 2023-10-23

A Study of HB0045 Injection in Patients With Advanced Solid Tumors

Shanghai Huaota Biopharmaceutical Co., Ltd.

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon ⚡